schliessen

Filtern

 

Bibliotheken

Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use

Purpose: Previous studies have emphasised that women with pre-existing mood disorders are more inclined to discontinue hormonal contraceptive use. However, few studies have examined the effects of combined oral contraceptives (COC) on mood in women with previous or ongoing mental disorders. Material... Full description

Journal Title: The European journal of contraception & reproductive health care 2018-01-02, Vol.23 (1), p.45-51
Main Author: Bengtsdotter, Hanna
Other Authors: Lundin, Cecilia , Gemzell Danielsson, Kristina , Bixo, Marie , Baumgart, Juliane , Marions, Lena , Brynhildsen, Jan , Malmborg, Agota , Lindh, Ingela , Sundström Poromaa, Inger
Format: Electronic Article Electronic Article
Language: English
Subjects:
Publisher: England: Taylor & Francis
ID: ISSN: 1362-5187
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_informaworld_taylorfrancis_310_1080_13625187_2017_1422239
title: Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use
format: Article
creator:
  • Bengtsdotter, Hanna
  • Lundin, Cecilia
  • Gemzell Danielsson, Kristina
  • Bixo, Marie
  • Baumgart, Juliane
  • Marions, Lena
  • Brynhildsen, Jan
  • Malmborg, Agota
  • Lindh, Ingela
  • Sundström Poromaa, Inger
subjects:
  • Adolescent
  • Adult
  • Affect - drug effects
  • alcohol
  • Alcohol Drinking - epidemiology
  • Alcohol Drinking - psychology
  • alcohol-consumption
  • anxiety
  • Anxiety Disorders - epidemiology
  • Anxiety Disorders - psychology
  • association
  • breast-cancer
  • Clinical Medicine
  • combined oral contraceptives
  • Contraceptives, Oral, Combined - adverse effects
  • depression
  • depressive symptoms
  • discontinuation
  • Double-Blind Method
  • Environmental & Occupational Health
  • Environmental Health and Occupational Health
  • epidemiology
  • Estradiol - adverse effects
  • Estrogens - adverse effects
  • Feeding and Eating Disorders - epidemiology
  • Feeding and Eating Disorders - psychology
  • Female
  • Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi
  • hormonal contraception
  • Humans
  • Klinisk medicin
  • major depression
  • mechanisms
  • Medical and Health Sciences
  • Medicin och hälsovetenskap
  • Megestrol - adverse effects
  • Mental Disorders
  • Miljömedicin och yrkesmedicin
  • Mood Disorders - epidemiology
  • Mood Disorders - psychology
  • Norpregnadienes - adverse effects
  • Obstetrics & Gynecology
  • Obstetrics, Gynecology and Reproductive Medicine
  • Progesterone Congeners - adverse effects
  • Psychiatric Status Rating Scales
  • Psychological Tests
  • Public
  • Public Health, Global Health, Social Medicine and Epidemiology
  • Randomised controlled trial
  • Randomised controlled trial
  • combined oral contraceptives
  • anxiety
  • depression
  • alcohol
  • Reproduktionsmedicin och gynekologi
  • Risk Factors
  • Severity of Illness Index
  • Sweden - epidemiology
  • women
  • Young Adult
ispartof: The European journal of contraception & reproductive health care, 2018-01-02, Vol.23 (1), p.45-51
description: Purpose: Previous studies have emphasised that women with pre-existing mood disorders are more inclined to discontinue hormonal contraceptive use. However, few studies have examined the effects of combined oral contraceptives (COC) on mood in women with previous or ongoing mental disorders. Materials and methods: This is a supplementary analysis of an investigator-initiated, double-blinded, randomised clinical trial during which 202 women were treated with either a COC (1.5 mg estradiol and 2.5 mg nomegestrolacetate) or placebo during three treatment cycles. The Mini International Neuropsychiatric Interview was used to collect information on previous or ongoing mental disorders. The primary outcome measure was the total change score in five mood symptoms on the Daily Record of Severity of Problems (DRSP) scale in the intermenstrual phase of the treatment cycle. Results: Women with ongoing or previous mood, anxiety or eating disorders allocated to COC had higher total DRSP Δ-scores during the intermenstrual phase of the treatment cycle in comparison with corresponding women randomised to placebo, mean difference 1.3 (95% CI 0.3-2.3). In contrast, among women without mental health problems, no difference in total DRSP Δ-scores between COC- and placebo users was noted. Women with a risk use of alcohol who were randomised to the COC had higher total DRSP Δ-scores than women randomised to placebo, mean difference 2.1 (CI 95% 1.0-3.2). Conclusions: Women with ongoing or previous mental disorders or risk use of alcohol have greater risk of COC-induced mood symptoms. This may be worth noting during family planning and contraceptive counselling.
language: eng
source:
identifier: ISSN: 1362-5187
fulltext: no_fulltext
issn:
  • 1362-5187
  • 1473-0782
  • 1473-0782
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.4927938
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_infor
recordidTN_cdi_informaworld_taylorfrancis_310_1080_13625187_2017_1422239
sourceformatXML
sourcesystemPC
sourcerecordid1989570355
originalsourceidFETCH-LOGICAL-c558t-ef9c297200768a043af617d4a9d1eef49b63f84901bdf6093dacf7904855039b0
addsrcrecordideNqNkktv1DAUhSMEoqXwE0BZsiCDn3EsNlQFWqRK3QBby4lvRoYkDn5M1X-PzUyLhNTCwrr29XeOZftU1UuMNhh16C2mLeG4ExuCsNhgRgih8lF1jJmgDRIdeZznmWkKdFQ9C-E7Qpgy2j6tjoikhHIhjqv1atk6u2xr5-vVw866FOoZlqin2tjgvAEfyk5erC5AHV2tzS43oZ6dM7WH1flYHEzypQxu7u0CJjtmj8Et0esB1mh3UKcAz6sno54CvDjUk-rrp49fzi6ay6vzz2enl83AeRcbGOVApCAIibbTiFE9tlgYpqXBACOTfUvHjkmEezO2SFKjh1FIxDrOEZU9Oqnk3jdcw5p6tXo7a3-jnLZ57ow69H_YMlQAhWl-NUwQz9rmXu02rSq3tqlISJtP6zL_5l7-g_12qpzfqpQU5RhR9KD9H3xOCrOWsP_kJ1t4gTuW-dd7Pt_zZ4IQ1WzDANOkF8jfq7DsJBeI8nJTvkcH70LwMN6ZY6RKztRtzlTJmTrkLOteHY5I_QzmTnUbrAy8-8t4sFFH-zsOdvqn_fu92i6j87O-dn4yKuqbyfnR62WwQdGHLX4BaY73kQ
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid1989570355
display
typearticle
titleOngoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use
creatorBengtsdotter, Hanna ; Lundin, Cecilia ; Gemzell Danielsson, Kristina ; Bixo, Marie ; Baumgart, Juliane ; Marions, Lena ; Brynhildsen, Jan ; Malmborg, Agota ; Lindh, Ingela ; Sundström Poromaa, Inger
creatorcontribBengtsdotter, Hanna ; Lundin, Cecilia ; Gemzell Danielsson, Kristina ; Bixo, Marie ; Baumgart, Juliane ; Marions, Lena ; Brynhildsen, Jan ; Malmborg, Agota ; Lindh, Ingela ; Sundström Poromaa, Inger ; Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi ; Sahlgrenska akademin ; Göteborgs universitet ; Gothenburg University ; Institute of Clinical Sciences, Department of Obstetrics and Gynecology ; Sahlgrenska Academy
descriptionPurpose: Previous studies have emphasised that women with pre-existing mood disorders are more inclined to discontinue hormonal contraceptive use. However, few studies have examined the effects of combined oral contraceptives (COC) on mood in women with previous or ongoing mental disorders. Materials and methods: This is a supplementary analysis of an investigator-initiated, double-blinded, randomised clinical trial during which 202 women were treated with either a COC (1.5 mg estradiol and 2.5 mg nomegestrolacetate) or placebo during three treatment cycles. The Mini International Neuropsychiatric Interview was used to collect information on previous or ongoing mental disorders. The primary outcome measure was the total change score in five mood symptoms on the Daily Record of Severity of Problems (DRSP) scale in the intermenstrual phase of the treatment cycle. Results: Women with ongoing or previous mood, anxiety or eating disorders allocated to COC had higher total DRSP Δ-scores during the intermenstrual phase of the treatment cycle in comparison with corresponding women randomised to placebo, mean difference 1.3 (95% CI 0.3-2.3). In contrast, among women without mental health problems, no difference in total DRSP Δ-scores between COC- and placebo users was noted. Women with a risk use of alcohol who were randomised to the COC had higher total DRSP Δ-scores than women randomised to placebo, mean difference 2.1 (CI 95% 1.0-3.2). Conclusions: Women with ongoing or previous mental disorders or risk use of alcohol have greater risk of COC-induced mood symptoms. This may be worth noting during family planning and contraceptive counselling.
identifier
0ISSN: 1362-5187
1ISSN: 1473-0782
2EISSN: 1473-0782
3DOI: 10.1080/13625187.2017.1422239
4PMID: 29323577
languageeng
publisherEngland: Taylor & Francis
subjectAdolescent ; Adult ; Affect - drug effects ; alcohol ; Alcohol Drinking - epidemiology ; Alcohol Drinking - psychology ; alcohol-consumption ; anxiety ; Anxiety Disorders - epidemiology ; Anxiety Disorders - psychology ; association ; breast-cancer ; Clinical Medicine ; combined oral contraceptives ; Contraceptives, Oral, Combined - adverse effects ; depression ; depressive symptoms ; discontinuation ; Double-Blind Method ; Environmental & Occupational Health ; Environmental Health and Occupational Health ; epidemiology ; Estradiol - adverse effects ; Estrogens - adverse effects ; Feeding and Eating Disorders - epidemiology ; Feeding and Eating Disorders - psychology ; Female ; Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi ; hormonal contraception ; Humans ; Klinisk medicin ; major depression ; mechanisms ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Megestrol - adverse effects ; Mental Disorders ; Miljömedicin och yrkesmedicin ; Mood Disorders - epidemiology ; Mood Disorders - psychology ; Norpregnadienes - adverse effects ; Obstetrics & Gynecology ; Obstetrics, Gynecology and Reproductive Medicine ; Progesterone Congeners - adverse effects ; Psychiatric Status Rating Scales ; Psychological Tests ; Public ; Public Health, Global Health, Social Medicine and Epidemiology ; Randomised controlled trial ; Randomised controlled trial; combined oral contraceptives; anxiety; depression; alcohol ; Reproduktionsmedicin och gynekologi ; Risk Factors ; Severity of Illness Index ; Sweden - epidemiology ; women ; Young Adult
ispartofThe European journal of contraception & reproductive health care, 2018-01-02, Vol.23 (1), p.45-51
rights2018 The European Society of Contraception and Reproductive Health 2018
lds50peer_reviewed
citedbyFETCH-LOGICAL-c558t-ef9c297200768a043af617d4a9d1eef49b63f84901bdf6093dacf7904855039b0
citesFETCH-LOGICAL-c558t-ef9c297200768a043af617d4a9d1eef49b63f84901bdf6093dacf7904855039b0
orcidid0000-0002-3327-9904 ; 0000-0002-0071-4383
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29323577$$D View this record in MEDLINE/PubMed
1$$Uhttp://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-147184$$DView record from Swedish Publication Index
2$$Uhttp://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-146240$$DView record from Swedish Publication Index
3$$Uhttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-351030$$DView record from Swedish Publication Index
4$$Uhttps://gup.ub.gu.se/publication/265508$$DView record from Swedish Publication Index
5$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:137821205$$DView record from Swedish Publication Index
search
creatorcontrib
0Bengtsdotter, Hanna
1Lundin, Cecilia
2Gemzell Danielsson, Kristina
3Bixo, Marie
4Baumgart, Juliane
5Marions, Lena
6Brynhildsen, Jan
7Malmborg, Agota
8Lindh, Ingela
9Sundström Poromaa, Inger
10Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi
11Sahlgrenska akademin
12Göteborgs universitet
13Gothenburg University
14Institute of Clinical Sciences, Department of Obstetrics and Gynecology
15Sahlgrenska Academy
title
0Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use
1The European journal of contraception & reproductive health care
addtitleEur J Contracept Reprod Health Care
descriptionPurpose: Previous studies have emphasised that women with pre-existing mood disorders are more inclined to discontinue hormonal contraceptive use. However, few studies have examined the effects of combined oral contraceptives (COC) on mood in women with previous or ongoing mental disorders. Materials and methods: This is a supplementary analysis of an investigator-initiated, double-blinded, randomised clinical trial during which 202 women were treated with either a COC (1.5 mg estradiol and 2.5 mg nomegestrolacetate) or placebo during three treatment cycles. The Mini International Neuropsychiatric Interview was used to collect information on previous or ongoing mental disorders. The primary outcome measure was the total change score in five mood symptoms on the Daily Record of Severity of Problems (DRSP) scale in the intermenstrual phase of the treatment cycle. Results: Women with ongoing or previous mood, anxiety or eating disorders allocated to COC had higher total DRSP Δ-scores during the intermenstrual phase of the treatment cycle in comparison with corresponding women randomised to placebo, mean difference 1.3 (95% CI 0.3-2.3). In contrast, among women without mental health problems, no difference in total DRSP Δ-scores between COC- and placebo users was noted. Women with a risk use of alcohol who were randomised to the COC had higher total DRSP Δ-scores than women randomised to placebo, mean difference 2.1 (CI 95% 1.0-3.2). Conclusions: Women with ongoing or previous mental disorders or risk use of alcohol have greater risk of COC-induced mood symptoms. This may be worth noting during family planning and contraceptive counselling.
subject
0Adolescent
1Adult
2Affect - drug effects
3alcohol
4Alcohol Drinking - epidemiology
5Alcohol Drinking - psychology
6alcohol-consumption
7anxiety
8Anxiety Disorders - epidemiology
9Anxiety Disorders - psychology
10association
11breast-cancer
12Clinical Medicine
13combined oral contraceptives
14Contraceptives, Oral, Combined - adverse effects
15depression
16depressive symptoms
17discontinuation
18Double-Blind Method
19Environmental & Occupational Health
20Environmental Health and Occupational Health
21epidemiology
22Estradiol - adverse effects
23Estrogens - adverse effects
24Feeding and Eating Disorders - epidemiology
25Feeding and Eating Disorders - psychology
26Female
27Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi
28hormonal contraception
29Humans
30Klinisk medicin
31major depression
32mechanisms
33Medical and Health Sciences
34Medicin och hälsovetenskap
35Megestrol - adverse effects
36Mental Disorders
37Miljömedicin och yrkesmedicin
38Mood Disorders - epidemiology
39Mood Disorders - psychology
40Norpregnadienes - adverse effects
41Obstetrics & Gynecology
42Obstetrics, Gynecology and Reproductive Medicine
43Progesterone Congeners - adverse effects
44Psychiatric Status Rating Scales
45Psychological Tests
46Public
47Public Health, Global Health, Social Medicine and Epidemiology
48Randomised controlled trial
49Randomised controlled trial; combined oral contraceptives; anxiety; depression; alcohol
50Reproduktionsmedicin och gynekologi
51Risk Factors
52Severity of Illness Index
53Sweden - epidemiology
54women
55Young Adult
issn
01362-5187
11473-0782
21473-0782
fulltextfalse
rsrctypearticle
creationdate2018
recordtypearticle
recordideNqNkktv1DAUhSMEoqXwE0BZsiCDn3EsNlQFWqRK3QBby4lvRoYkDn5M1X-PzUyLhNTCwrr29XeOZftU1UuMNhh16C2mLeG4ExuCsNhgRgih8lF1jJmgDRIdeZznmWkKdFQ9C-E7Qpgy2j6tjoikhHIhjqv1atk6u2xr5-vVw866FOoZlqin2tjgvAEfyk5erC5AHV2tzS43oZ6dM7WH1flYHEzypQxu7u0CJjtmj8Et0esB1mh3UKcAz6sno54CvDjUk-rrp49fzi6ay6vzz2enl83AeRcbGOVApCAIibbTiFE9tlgYpqXBACOTfUvHjkmEezO2SFKjh1FIxDrOEZU9Oqnk3jdcw5p6tXo7a3-jnLZ57ow69H_YMlQAhWl-NUwQz9rmXu02rSq3tqlISJtP6zL_5l7-g_12qpzfqpQU5RhR9KD9H3xOCrOWsP_kJ1t4gTuW-dd7Pt_zZ4IQ1WzDANOkF8jfq7DsJBeI8nJTvkcH70LwMN6ZY6RKztRtzlTJmTrkLOteHY5I_QzmTnUbrAy8-8t4sFFH-zsOdvqn_fu92i6j87O-dn4yKuqbyfnR62WwQdGHLX4BaY73kQ
startdate20180102
enddate20180102
creator
0Bengtsdotter, Hanna
1Lundin, Cecilia
2Gemzell Danielsson, Kristina
3Bixo, Marie
4Baumgart, Juliane
5Marions, Lena
6Brynhildsen, Jan
7Malmborg, Agota
8Lindh, Ingela
9Sundström Poromaa, Inger
generalTaylor & Francis
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
87X8
9ADTPV
10AOWAS
orcidid
0https://orcid.org/0000-0002-3327-9904
1https://orcid.org/0000-0002-0071-4383
sort
creationdate20180102
titleOngoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use
authorBengtsdotter, Hanna ; Lundin, Cecilia ; Gemzell Danielsson, Kristina ; Bixo, Marie ; Baumgart, Juliane ; Marions, Lena ; Brynhildsen, Jan ; Malmborg, Agota ; Lindh, Ingela ; Sundström Poromaa, Inger
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c558t-ef9c297200768a043af617d4a9d1eef49b63f84901bdf6093dacf7904855039b0
rsrctypearticles
prefilterarticles
languageeng
creationdate2018
topic
0Adolescent
1Adult
2Affect - drug effects
3alcohol
4Alcohol Drinking - epidemiology
5Alcohol Drinking - psychology
6alcohol-consumption
7anxiety
8Anxiety Disorders - epidemiology
9Anxiety Disorders - psychology
10association
11breast-cancer
12Clinical Medicine
13combined oral contraceptives
14Contraceptives, Oral, Combined - adverse effects
15depression
16depressive symptoms
17discontinuation
18Double-Blind Method
19Environmental & Occupational Health
20Environmental Health and Occupational Health
21epidemiology
22Estradiol - adverse effects
23Estrogens - adverse effects
24Feeding and Eating Disorders - epidemiology
25Feeding and Eating Disorders - psychology
26Female
27Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi
28hormonal contraception
29Humans
30Klinisk medicin
31major depression
32mechanisms
33Medical and Health Sciences
34Medicin och hälsovetenskap
35Megestrol - adverse effects
36Mental Disorders
37Miljömedicin och yrkesmedicin
38Mood Disorders - epidemiology
39Mood Disorders - psychology
40Norpregnadienes - adverse effects
41Obstetrics & Gynecology
42Obstetrics, Gynecology and Reproductive Medicine
43Progesterone Congeners - adverse effects
44Psychiatric Status Rating Scales
45Psychological Tests
46Public
47Public Health, Global Health, Social Medicine and Epidemiology
48Randomised controlled trial
49Randomised controlled trial; combined oral contraceptives; anxiety; depression; alcohol
50Reproduktionsmedicin och gynekologi
51Risk Factors
52Severity of Illness Index
53Sweden - epidemiology
54women
55Young Adult
toplevelpeer_reviewed
creatorcontrib
0Bengtsdotter, Hanna
1Lundin, Cecilia
2Gemzell Danielsson, Kristina
3Bixo, Marie
4Baumgart, Juliane
5Marions, Lena
6Brynhildsen, Jan
7Malmborg, Agota
8Lindh, Ingela
9Sundström Poromaa, Inger
10Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi
11Sahlgrenska akademin
12Göteborgs universitet
13Gothenburg University
14Institute of Clinical Sciences, Department of Obstetrics and Gynecology
15Sahlgrenska Academy
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7MEDLINE - Academic
8SwePub
9SwePub Articles
jtitleThe European journal of contraception & reproductive health care
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0Bengtsdotter, Hanna
1Lundin, Cecilia
2Gemzell Danielsson, Kristina
3Bixo, Marie
4Baumgart, Juliane
5Marions, Lena
6Brynhildsen, Jan
7Malmborg, Agota
8Lindh, Ingela
9Sundström Poromaa, Inger
aucorp
0Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi
1Sahlgrenska akademin
2Göteborgs universitet
3Gothenburg University
4Institute of Clinical Sciences, Department of Obstetrics and Gynecology
5Sahlgrenska Academy
formatjournal
genrearticle
ristypeJOUR
atitleOngoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use
jtitleThe European journal of contraception & reproductive health care
addtitleEur J Contracept Reprod Health Care
date2018-01-02
risdate2018
volume23
issue1
spage45
epage51
pages45-51
issn
01362-5187
11473-0782
eissn1473-0782
abstractPurpose: Previous studies have emphasised that women with pre-existing mood disorders are more inclined to discontinue hormonal contraceptive use. However, few studies have examined the effects of combined oral contraceptives (COC) on mood in women with previous or ongoing mental disorders. Materials and methods: This is a supplementary analysis of an investigator-initiated, double-blinded, randomised clinical trial during which 202 women were treated with either a COC (1.5 mg estradiol and 2.5 mg nomegestrolacetate) or placebo during three treatment cycles. The Mini International Neuropsychiatric Interview was used to collect information on previous or ongoing mental disorders. The primary outcome measure was the total change score in five mood symptoms on the Daily Record of Severity of Problems (DRSP) scale in the intermenstrual phase of the treatment cycle. Results: Women with ongoing or previous mood, anxiety or eating disorders allocated to COC had higher total DRSP Δ-scores during the intermenstrual phase of the treatment cycle in comparison with corresponding women randomised to placebo, mean difference 1.3 (95% CI 0.3-2.3). In contrast, among women without mental health problems, no difference in total DRSP Δ-scores between COC- and placebo users was noted. Women with a risk use of alcohol who were randomised to the COC had higher total DRSP Δ-scores than women randomised to placebo, mean difference 2.1 (CI 95% 1.0-3.2). Conclusions: Women with ongoing or previous mental disorders or risk use of alcohol have greater risk of COC-induced mood symptoms. This may be worth noting during family planning and contraceptive counselling.
copEngland
pubTaylor & Francis
pmid29323577
doi10.1080/13625187.2017.1422239
orcidid
0https://orcid.org/0000-0002-3327-9904
1https://orcid.org/0000-0002-0071-4383